The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 13, 2020

Filed:

Nov. 16, 2015
Applicant:

Array Biopharma, Inc., Boulder, CO (US);

Inventors:

Alisha B. Arrigo, Boulder, CO (US);

Derrick Juengst, Boulder, CO (US);

Khalid Shah, South San Francisco, CA (US);

Assignee:

Array BioPharma, Inc., Boulder, CO (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 487/04 (2006.01); A61K 31/519 (2006.01); C12Q 1/48 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); C07D 487/04 (2013.01); C12Q 1/485 (2013.01); C12Y 207/10001 (2013.01); G01N 2333/91205 (2013.01); G01N 2800/52 (2013.01); Y02A 50/414 (2018.01);
Abstract

A novel crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide, pharmaceutical compositions containing said crystalline form and the use of said crystalline form in the treatment of pain, cancer, inflammation, neurodegenerative disease orinfection are disclosed. In some embodiments, the novel crystalline form comprises a stable polymorph of (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate. The present invention is further directed to a process for the preparation of the novel crystalline form.


Find Patent Forward Citations

Loading…